Home›People›Daniel Kraft
Daniel Kraft

Daniel Kraft

Board Member at Immunis.

Director
Updated Nov 10, 2026·Latest SEC filing Jun 15, 2026·Suggest an edit

About Daniel Kraft

Daniel Kraft is a board member at Immunis.

Daniel Kraft first appears on SEC filings in 2024.

Experience

This experience comes from Daniel Kraft's profile and from SEC filings. For roles taken from filings, the years are when the filings name Daniel Kraft in the role, so the role may have started earlier or lasted longer.

Stanford University School of Medicine Current
Adjunct Professor
2026 – Present
Immunis, Inc. Current
Board Member
2023 – Present · Irvine, CA
Develops investigational therapies for people with age-related muscle and metabolic diseases.
Digital.Health Current
Founder
2022 – Present
Continuum Health Ventures Current
General Partner
2021 – Present
XPRIZE Current
Chair, XPRIZE Pandemic & Health Alliance
2020 – Present
Healthy Conversations Podcast Current
Host
2020 – Present
The Commons Project Foundation Current
Trustee
2020 – Present
Healthy.io Current
Board Of Directors
2019 – Present
Tech Nation Health / Biotech Nation Current
Chief Correspondent
2016 – Present
Aspen Institute Current
Health Innovator Fellow
2015 – Present
IntelliMedicine Current
Founder
2015 – Present
NextMed Health Current
Founder & Chair
2011 – Present
RegenMed Systems Current
Founder
2010 – Present
Singularity University Current
Faculty Chair for Medicine & Neuroscience, Singularity University
2009 – Present
Exponential Medicine
Founder and Chair
2011 – 2019
Exponential Partners
Chief Medical Advisor
2016 – 2018
Cancer XPRIZE
Bold Innovator - Cancer XPRIZE
2016 – 2017
California Air National Guard
Officer, Flight Surgeon, F-15 and F-16 Fighter Squadrons, 102nd FW and 144th Fighter Wing
1999 – 2014
FutureMed
Founder and Executive Director
2011 – 2013

Key Colleagues at Startups

The people Daniel Kraft works with at each company, as listed on that company's latest Form D.

Immunis, Inc. · Form D, Jun 15, 2026
Takahide Koda
Takahide Koda
Board Member
GN
Gabriel Nistor
Executive officer

Sources

  1. SECImmunis, Inc. Form D, filed Jun 15, 2026